Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
20 participants
INTERVENTIONAL
2015-01-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Photobiomodulation Therapy in Persons With Multiple Sclerosis
NCT03691766
Vitamine D in Multiple Sclerosis
NCT01768039
Light Therapy as Treatment for Fatigue in Multiple Sclerosis
NCT03060759
Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis
NCT06261528
Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis
NCT05340985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phototherapy
This arm involves exposure to a UVB phototherapy device 3 times per week over 8 weeks.
Phototherapy
Participants will be exposed to phototherapy according to the 2014 Guidelines issued by the American Academy of Dermatology 3 days per week over an 8-week period.
Shame phototherapy
This arm is identical with experimental arm, except that participants will be exposed to non-UVB florescent light.
Phototherapy
Participants will be exposed to phototherapy according to the 2014 Guidelines issued by the American Academy of Dermatology 3 days per week over an 8-week period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phototherapy
Participants will be exposed to phototherapy according to the 2014 Guidelines issued by the American Academy of Dermatology 3 days per week over an 8-week period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known medical history of calcium disorder or knowledge of high calcium levels
* Known medical history of hyper-parathyroidism
* Current supplementation with oral vitamin D
* Known allergy to vitamin D
* History of cancer of any type including but not limited to skin cancer
* Obesity defined as BMI \> 30
* Known history of fat malabsorption conditions (i.e., steatorrhea)
* Current use of anti-epileptic medication
* Current use of glucocorticoids
* Fitzpatrick skin types I and VI using the Fitzpatrick skin type analysis
* Recent use of tanning facilities
18 Years
64 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Illinois at Urbana-Champaign
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert W Motl, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Illinois at Urbana-Champaign
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Exercise Neuroscience Research Laboratory
Urbana, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15178
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.